Former Dallas Cowboys Player Marshawn Kneeland Diagnosed with Stage 1 CTE
The family of former Dallas Cowboys player Marshawn Kneeland announced that Kneeland was diagnosed with Stage 1 Chronic Traumatic Encephalopathy (CTE), according to the Concussion & CTE Foundation. The diagnosis comes as part of a broader effort to highlight the long-term neurological impact of repetitive head trauma in professional contact sports.
What is Stage 1 CTE and how does it affect athletes?
Chronic Traumatic Encephalopathy is a progressive brain disease found in people with a history of repetitive brain trauma, including symptomatic concussions as well as non-symptomatic hits. According to the Concussion & CTE Foundation, Stage 1 is the earliest phase of the disease. In this stage, individuals often experience mild symptoms such as headaches, loss of focus, and short-term memory loss.
Unlike a standard concussion, which is an acute injury, CTE is a degenerative disease. The Boston University CTE Center, a leading research body on the condition, notes that the disease is characterized by the buildup of an abnormal protein called tau in the brain, which gradually kills brain cells.
Why the diagnosis for Marshawn Kneeland matters
Kneeland’s diagnosis adds to a growing body of evidence linking professional football to permanent brain damage. By sharing this information through the Concussion & CTE Foundation, the family aims to raise awareness about the “silent” nature of the disease, which can often be misdiagnosed as depression or early-onset dementia in its later stages.
This development follows a pattern seen with other NFL alumni. While the league has implemented “concussion protocols” and rule changes to limit head-to-head contact, the diagnosis of former players continues to drive demand for better diagnostic tools that can detect CTE in living patients, rather than only during post-mortem examinations.
How is CTE diagnosed in living patients?
Historically, CTE could only be confirmed via autopsy. However, the Concussion & CTE Foundation and associated researchers are working toward biomarkers and advanced imaging to identify the disease in living athletes. Current “diagnoses” in living patients are typically based on clinical symptoms and a history of head trauma, though they are often referred to as “probable” or “stage-based” assessments until pathological confirmation is possible.
Comparison of CTE Progression
| Stage | Common Symptoms | Neurological Impact |
|---|---|---|
| Stage 1 | Headaches, irritability, memory lapses | Mild tau protein accumulation |
| Stage 2 | Mood swings, depression, executive dysfunction | Increased protein spread in frontal cortex |
| Stage 3/4 | Dementia, aggression, severe cognitive decline | Widespread brain atrophy and tau deposits |
What happens next for CTE research?
The focus for medical researchers now remains on prevention and early detection. The NFL continues to update its Game Day Concussion Diagnosis and Management Protocol, but the Concussion & CTE Foundation emphasizes that the goal must be the total reduction of sub-concussive hits—the smaller, repeated impacts that occur during every tackle.
For athletes like Kneeland, the focus shifts to symptom management and providing a roadmap for other former players to seek neurological screenings.
Keep reading